BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
32 hedge funds and large institutions have $27.5M invested in Biolase, Inc. in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$60.7K | |
| 2 | +$49K | |
| 3 | +$34K | |
| 4 |
Goldman Sachs
New York
|
+$27.5K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$27K |
Top Sellers
| 1 | -$109K | |
| 2 | -$72.6K | |
| 3 | -$60.5K | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$48.6K |
| 5 |
D.E. Shaw & Co
New York
|
-$25.3K |